{"id":"botox-allergan","safety":{"commonSideEffects":[{"rate":"5–15%","effect":"Headache"},{"rate":"10–20%","effect":"Neck pain"},{"rate":"5–10%","effect":"Injection site pain"},{"rate":"5–10%","effect":"Muscle weakness"},{"rate":"1–5%","effect":"Eyelid ptosis"},{"rate":"1–5%","effect":"Dry mouth"},{"rate":"1–3%","effect":"Flu-like symptoms"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Botulinum toxin type A binds to presynaptic nerve terminals and cleaves SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins, preventing acetylcholine vesicles from fusing with the cell membrane. This results in temporary muscle paralysis lasting 3–4 months. The effect is reversible as the body gradually regenerates new nerve terminals.","oneSentence":"BOTOX blocks the release of acetylcholine at the neuromuscular junction by cleaving SNARE proteins, causing temporary paralysis of muscles.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:41:56.048Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cervical dystonia"},{"name":"Blepharospasm"},{"name":"Strabismus"},{"name":"Chronic migraine"},{"name":"Hyperhidrosis"},{"name":"Glabellar lines (cosmetic)"},{"name":"Crow's feet (cosmetic)"}]},"trialDetails":[{"nctId":"NCT06174155","phase":"NA","title":"Comparative Study Between Botulinum Toxin-A Injection and Shock Waves on Hypertrophic Scars in Hand-burned Children","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-12-15","conditions":"Hand-burned Children","enrollment":60},{"nctId":"NCT07360483","phase":"NA","title":"Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-01-01","conditions":"Hypertrophic Scars","enrollment":48},{"nctId":"NCT07331844","phase":"NA","title":"BTX-A and Mirror Therapy for Chronic Stroke Spasticity","status":"COMPLETED","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2024-05-15","conditions":"Stroke, Spastic Hemiplegia","enrollment":30},{"nctId":"NCT01955174","phase":"PHASE2","title":"Botulinum Toxin Injection in Hypercontractile Esophagus","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2013-08","conditions":"Nutcracker Oesophagus","enrollment":24},{"nctId":"NCT03187626","phase":"PHASE2, PHASE3","title":"Efficacy of an Intra-articular Injection of Botulinum Toxin A Associated With Splinting for Base-of-thumb Osteoarthritis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-11-29","conditions":"Base-of-thumb Osteoarthritis","enrollment":60},{"nctId":"NCT07013240","phase":"PHASE3","title":"Botulinum Toxin Injection After Sternotomies to Improve Scar Aspect and Impact","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2025-07-05","conditions":"Sternotomy Closure,Open Heart Surgery","enrollment":50},{"nctId":"NCT06296082","phase":"PHASE2, PHASE3","title":"Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity","status":"RECRUITING","sponsor":"Universiteit Antwerpen","startDate":"2024-09-01","conditions":"Stroke","enrollment":90},{"nctId":"NCT06778421","phase":"PHASE1","title":"Impact of OnabotulinumtoxinA (BOTOX®) on Stress","status":"RECRUITING","sponsor":"Center for Advanced Facial Plastic Surgery","startDate":"2025-01-20","conditions":"Stress (Psychology), Stress, Healthy Adult Female Participants","enrollment":20},{"nctId":"NCT06448676","phase":"PHASE4","title":"Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides","status":"NOT_YET_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-01-01","conditions":"Wrinkle","enrollment":200},{"nctId":"NCT03453632","phase":"PHASE2, PHASE3","title":"Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex","status":"UNKNOWN","sponsor":"University Hospital, Toulouse","startDate":"2018-06-14","conditions":"Epidermolysis Bullosa Simplex","enrollment":25},{"nctId":"NCT05771623","phase":"NA","title":"Botulinum Toxin Type a Iontophoresis for Postburn Hypertrophic Scar","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-08-01","conditions":"Hypertrophic Scar","enrollment":76},{"nctId":"NCT05822323","phase":"NA","title":"Effect of Botulinum Toxin-A on Free Gingival Graft","status":"COMPLETED","sponsor":"Kevser Sokmen","startDate":"2019-10-01","conditions":"Gingival Recession, Localized","enrollment":40},{"nctId":"NCT03555916","phase":"PHASE3","title":"Botulinum Toxin Injections for Oral Neuropathic Pain","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-04-04","conditions":"Trigeminal Neuropathy, Traumatic","enrollment":43},{"nctId":"NCT05651256","phase":"PHASE2, PHASE3","title":"Efficacy of Botulinum Toxin in Temporomandibular Disorders","status":"COMPLETED","sponsor":"University of Salamanca","startDate":"2021-03-01","conditions":"Temporomandibular Joint Disorder Bilateral","enrollment":20},{"nctId":"NCT02555982","phase":"PHASE3","title":"Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2016-06-27","conditions":"Essential Head Tremor","enrollment":120},{"nctId":"NCT01698138","phase":"PHASE4","title":"Prevention of Bladder Dysfunction in Acute Spinal Cord Injury","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2012-09","conditions":"Spinal Cord Injuries, Urinary Bladder, Overactive","enrollment":20},{"nctId":"NCT05620316","phase":"NA","title":"The Use of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle to Treat Sleep Bruxism","status":"COMPLETED","sponsor":"Damascus University","startDate":"2021-03-15","conditions":"Nocturnal Bruxism","enrollment":22},{"nctId":"NCT05099835","phase":"NA","title":"Ultrasound-Guided Stellate Ganglion Block With Botulinum","status":"COMPLETED","sponsor":"Assiut University","startDate":"2021-11-01","conditions":"Change From Baseline House-Brackmann","enrollment":60},{"nctId":"NCT03717961","phase":"PHASE3","title":"Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-10-15","conditions":"Raynaud Phenomenon Secondary to Systemic Sclerosis","enrollment":91},{"nctId":"NCT01004042","phase":"PHASE4","title":"Quality of Life and Self-esteem After Botox® Injections in Depressed and Non-depressed Patients","status":"COMPLETED","sponsor":"Hexsel Dermatology Clinic","startDate":"2009-10","conditions":"Depression, Quality of Life","enrollment":50},{"nctId":"NCT00711087","phase":"PHASE2","title":"Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)","status":"TERMINATED","sponsor":"Baylor College of Medicine","startDate":"2007-07","conditions":"Neurogenic Bladder Dysfunction Nos, Spinal Cord Injury","enrollment":1},{"nctId":"NCT04075578","phase":"","title":"Evaluation of Professional Practices in the Treatment of Refractory Idiopathic Overactive Bladder at the Dose of 50 Units (TOX50IUU)","status":"UNKNOWN","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2019-06-26","conditions":"Bladder, Overactive","enrollment":60},{"nctId":"NCT01821573","phase":"PHASE3","title":"Study of the Effect of Botulinum Toxin Injection in Rectus Femoris and Triceps on the Length and the Strength During Locomotion in Chronic Hemiparetic Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-07","conditions":"COMPARISON BETWEEN GROUP TREATED WITH BOTULINUM TOXIN AND PLACEBO","enrollment":36},{"nctId":"NCT01325090","phase":"PHASE3","title":"Early Administration of Botox® in Neuropathic Pain Due to Thoracoscopy or Thoracotomy","status":"WITHDRAWN","sponsor":"University Hospital, Limoges","startDate":"2011-05","conditions":"Pain Due to Certain Specified Procedures, Neuropathic Pain","enrollment":""},{"nctId":"NCT03407183","phase":"","title":"The Efficacy of Botulinum Toxin in Spastic Neuropathic Bladder","status":"UNKNOWN","sponsor":"AHMED FARAHAT HASSAN","startDate":"2018-01-01","conditions":"Spastic Neurogenic Bladder","enrollment":20},{"nctId":"NCT03048383","phase":"PHASE4","title":"Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis","status":"COMPLETED","sponsor":"University of Utah","startDate":"2012-07","conditions":"Facial Nerve Injuries, Facial Paresis Associated With Facial Nerve Dysfunction, Facial Asymmetry","enrollment":71},{"nctId":"NCT01332474","phase":"","title":"JCP Study of Investigation of Patient Background Characteristics","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-05","conditions":"Spasticity, Post-Stroke","enrollment":326},{"nctId":"NCT01180348","phase":"PHASE3","title":"Efficacy and Safety of a New Botulinum Toxin Type A for Treatment of Facial Expression Lines","status":"COMPLETED","sponsor":"Azidus Brasil","startDate":"2011-08","conditions":"Wrinkles","enrollment":192},{"nctId":"NCT01390922","phase":"","title":"Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-08","conditions":"Mumps","enrollment":1038},{"nctId":"NCT00930709","phase":"NA","title":"Botulinum Toxin Versus Active Strength Training in the Treatment of Lateral Epicondylitis","status":"COMPLETED","sponsor":"Seinajoki Central Hospital","startDate":"2009-03","conditions":"Epicondylitis, Lateral Humeral, Tennis Elbow","enrollment":103},{"nctId":"NCT01910363","phase":"PHASE2, PHASE3","title":"Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke","status":"UNKNOWN","sponsor":"University of Tokushima","startDate":"2013-07","conditions":"Lower Limb Spasticity After Stroke","enrollment":30},{"nctId":"NCT01590693","phase":"NA","title":"Botulinum Toxin A for Idiopathic Toe-walking","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2005-11","conditions":"Idiopathic Toe-walking","enrollment":52},{"nctId":"NCT00827736","phase":"PHASE4","title":"Comparison of Treatment Success of Botox Injection in the Internal Sphincter Versus Isosorbidedinitrate Ointment in Patients With an Anal Fissure","status":"COMPLETED","sponsor":"Onze Lieve Vrouwe Gasthuis","startDate":"2002-06","conditions":"Anal Fissure","enrollment":73}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":203,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["BOTOX"],"phase":"phase_3","status":"active","brandName":"BOTOX®, Allergan","genericName":"BOTOX®, Allergan","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BOTOX blocks the release of acetylcholine at the neuromuscular junction by cleaving SNARE proteins, causing temporary paralysis of muscles. Used for Cervical dystonia, Blepharospasm, Strabismus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}